Medical/Pharmaceuticals
New Mountain Capital to Acquire Flexan
NEW YORK, July 27, 2021 /PRNewswire/ -- An affiliate of New Mountain Capital, LLC ("New Mountain") announced that it has reached a definitive agreement to acquire Flexan, a leading medical device contract design and manufacturing organization that specializes in silicone, thermoplastic, and speci...
2021-07-27 18:00
3265
MicroPort® Cardiac Rhythm Management Business Announces US$150 Million Series C Investment
SHANGHAI, July 27, 2021 /PRNewswire/ -- MicroPort Scientific Corporation (" MicroPort®") announced that MicroPort Cardiac Rhythm Management Limited (" MicroPort® CRM"), which is MicroPort®'s subsidiary focused on developing and commercializing implantable pacemaker and defibrillator devices and rel...
2021-07-27 15:42
13476
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions
-- Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. -- New sites opening in US and UK to realize regional manufacturing models. Overall, the companies plan to hire 2000 full-time associates...
2021-07-27 14:05
4478
CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan
KFAR-SABA, Israel and ALISO VIEJO, Calif., July 26, 2021 /PRNewswire/ -- CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System, making it more broadly available for coronary arte...
2021-07-26 22:00
2880
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in Canada
RARITAN, N.J., July 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care...
2021-07-26 21:00
6173
Beckman Coulter to Distribute BNP Cardiac Assay to Customers
- Beckman Coulter to take over distribution to customers of a B-type Natriuretic Peptide (BNP) assay, a marker of congestive heart failure on the company's immunoassay platforms - This BNP assay for Beckman Coulter immunoassay analyzers, currently sold as TRIAGE® BNP by Quidel, will now be sold ...
2021-07-26 20:56
6119
PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference
DAEJEON, South Korea, July 26, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics, announced today that the company is invited to deliver a video presentation at H.C Wainwright Ophthalmolo...
2021-07-26 20:00
1977
HBM Presents Phase I Data on Next-Generation Anti-CTLA-4 Antibody at ESMO Congress 2021
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, July 26, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) today announced that the abstract detailing clinical data from its Australian phase I study of next-generation anti-CTLA-4 antibody in patients with advanced solid tumo...
2021-07-26 19:11
5369
Collaborative Drug Discovery (CDD) Launches BioHarmony
New Data Offering Provides LIVE Feeds about Drugs from Diverse Sources (Pre-clinical, Clinical & Post-Clinical) SAN FRANCISCO, July 26, 2021 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD), provider of the web-based drug discovery informatics platform CDD Vault, announces the launch of ...
2021-07-26 18:57
1502
100-day countdown begins for the fourth CIIE
SHANGHAI, China, July 26, 2021 /PRNewswire/ -- The 4th China International
Import Expo (CIIE), the world's largest import-themed expo, will be held in
Shanghai from Nov 5 to 10, organizers announced during a briefing to mark the
100-day countdown to the event onJuly 26.
2021-07-26 18:03
758
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility
* First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system * Only 12 months from facility qualification to licensure demonstrating global adoption of "WuXi Biologics Speed" LEVERKUSEN, Germany, July 26, 2021 /PRNewswire/ -- WuXi Biologics (...
2021-07-26 18:00
4534
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors
HOUSTON and SINGAPORE, July 26, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that internationally renowned scientist and medical oncologist, Dr. Thomas J Lynch, Jr,...
2021-07-26 17:00
1748
Global Medical Imaging & Informatics Market Thrives with AI and Cloud as Healthcare Sector Focuses on Quadruple Aim
The global medical imaging and informatics market is estimated to hit $37.10 billion in 2021 from $33.90 billion in 2020, registering growth at 9.4%, finds Frost & Sullivan SANTA CLARA, Calif., July 26, 2021 /PRNewswire/ -- The healthcare sector's emphasis on meeting its Quadruple Aim goal—cost ...
2021-07-26 16:02
1906
Laekna Therapeutics will present two clinical study results in ESMO 2021
SHANGHAI and WARREN, N.J., July 26, 2021 /PRNewswire/ -- Laekna Therapeutics, an emerging innovative pharma company based inChina's "Zhangjiang Pharma Valley" andNew Jersey in the U.S. and focused on developing new groundbreaking innovative therapies to treat cancer and liver diseases, announced ...
2021-07-26 13:26
3605
Manulife Hong Kong joins hands with Hong Kong Baptist Hospital to strengthen health solutions offering
HONG KONG, July 26, 2021 /PRNewswire/ -- Manulife Hong Kong announced a partnership with Hong Kong Baptist Hospital (HKBH) today to expand its health solutions and network of healthcare providers. To meet the growing demand for convenient, high quality and affordable medical services, the new col...
2021-07-26 12:25
4031
Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections
SHANGHAI and HONG KONG, July 26, 2021 /PRNewswire/ -- In June 2021, results from a preclinical study jointly conducted by Antengene, American biopharmaceutical company Karyopharm Therapeutics andUniversity of Georgia College of Veterinary Medicine has been published in a paper titled "selinexor, ...
2021-07-26 08:44
3767
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors
SAN FRANCISCO and SUZHOU, China, July 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-26 08:00
7632
ZumVet launches first virtual veterinary platform in Hong Kong
HONG KONG, July 26, 2021 /PRNewswire/ -- Singapore-based pet telehealth startup ZumVet today announced the launch of its platform inHong Kong, a remote care solution offering a full suite of home-based health and wellness services for pets. This is the first pet-centric app of its kind inHong ...
2021-07-26 06:00
4175
The Global Self-Care Federation Highlights the Need to Take Action on Self-Care to Create Better Health Outcomes for All
GENÈVE, Switzerland, July 23, 2021 /PRNewswire/ -- On the occasion of International Self-Care Day 2021 and WHO Self-Care month, The Global Self-Care Federation (GSCF) underscores the importance of acting on self-care by engaging in positive and consistent self-care practices. Self-care produces o...
2021-07-23 21:41
3373
GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices
ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterloader systems, including service agreements. The cancer treatment devices will allow GenesisCare to contin...
2021-07-23 21:02
9397
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 290 media titles]
2026-05-18 15:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15Most Read
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
6824
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
6752
/C O R R E C T I O N -- The American Chamber of Commerce in Singapore (AmChamSG)/
2026-05-21 12:14
6269
NYSE Content Update: Armada Raises $230 Million, Boosts Valuation to $2 Billion
2026-05-19 21:02
6202
